Nuvo Pharmaceuticals Begins Trading on the OTCQX Market

Nuvo Pharmaceuticals (TSX:NRI; OTCQX:NRIFF) announced its common stock has started trading on the OTCQX market in the US, under the symbol NRIFF.
As quoted in the press release:

“The OTCQX market will provide our current and future shareholder base with increased visibility and transparency through high-quality disclosure, transparent trading and ease of access to Company information.  We appreciate that some investors prefer to trade in U.S. dollars and upgrading to the OTCQX will facilitate this trading,” stated Jesse Ledger, Nuvo’s President and CEO.
U.S. investors can find current financial disclosures and Real-Time level 2 quotes for the Company on www.otcmarkets.com.
“Nuvo joins over 100 Canadian companies together representing $30 billion in market capitalization that cross-trade their shares on our OTCQX Best Market,” said Jason Paltrowitz, Executive Vice President of OTC Markets Group. “OTCQX enables international companies to efficiently provide U.S. investors with transparent trading and convenient access to their news and financials.  We look forward to supporting Nuvo in the U.S. public market.”

Click here to read the full press release.

Source: www.newswire.ca